For many people, asthma control means one simple thing: not having symptoms. If there is no wheezing, no coughing, and no need for an inhaler, it is easy to assume the disease is under control. But according to experts in respiratory medicine, asthma may continue causing silent damage even when patients feel relatively well.

The Invisible Disease

Asthma has always posed a peculiar challenge for physicians because symptoms do not reliably reflect what is happening inside the lungs.

Unlike a broken bone or a skin rash, asthma is largely invisible. Airways can remain inflamed even when breathing feels normal. Patients may gradually reduce activity levels, avoid exercise, sleep poorly, or normalize chest tightness without consciously recognizing these changes as signs of worsening disease. This adaptation can create a dangerous illusion of stability.

The consensus panel reviewed more than 200 scientific publications and found enormous variation in how asthma control is defined and measured. Some clinicians focus heavily on symptoms. Others prioritize lung function tests or the frequency of asthma attacks. Even the most commonly used questionnaires, the Asthma Control Test (ACT) and Asthma Control Questionnaire (ACQ), use differing thresholds depending on the study or clinic.

The result is a fragmented landscape in which the same patient may be classified as “controlled” by one standard and “poorly controlled” by another.

The Gap Between Patients and Physicians

Perhaps the most revealing aspect of the report is the disconnect between how doctors and patients perceive asthma itself. Physicians tend to think in terms of physiology and future risk. They worry about airway remodeling, declining lung function, inflammation, and the possibility of severe exacerbations years later.

Patients, by contrast, often think pragmatically. Can they get through work? Sleep at night? Walk upstairs? Exercise without embarrassment? Many define control not as the absence of disease, but as the ability to tolerate symptoms below a personally acceptable threshold. This difference may explain why asthma is frequently underreported during office visits. Patients may say they are “fine” while quietly limiting their lives in ways they no longer notice.

The experts noted that although most healthcare professionals believe they share treatment goals with their patients, many simultaneously acknowledge that the two groups value different measures of success.

The Modern Shift: Predicting the Future

Asthma medicine is increasingly moving away from a reactive model, treating flare-ups after they occur, toward a predictive one focused on preventing long-term damage.In this framework, asthma control is not just about how patients feel today. It is also about the probability of what might happen tomorrow.

Frequent exacerbations, emergency room visits, repeated steroid use, and declining lung function are now viewed as warning signs of ongoing instability, even in patients with relatively mild daily symptoms. This shift reflects a broader transformation occurring throughout medicine. Diseases once judged primarily by symptoms are increasingly understood through underlying biological activity. Hypertension can damage arteries silently. Diabetes can injure organs before symptoms appear. Asthma, researchers argue, may behave similarly.

Even the humble rescue inhaler has become a marker of hidden disease activity. Heavy reliance on short-acting beta agonists, or SABAs, may signal unstable airways long before patients recognize worsening control themselves.

The Adherence Problem

One of the paper’s most striking findings concerns medication adherence. Nearly 90 percent of specialists agreed that adherence should be central to evaluating asthma control. Yet among the hundreds of studies reviewed, virtually none formally incorporated adherence into their definitions of control. This omission highlights one of the most persistent problems in asthma care: people often stop treatment once they feel better.

Controller inhalers are designed not simply to relieve symptoms but to suppress underlying inflammation over time. The paradox is that successful treatment can create the illusion that medication is no longer necessary. For many patients, asthma behaves less like an infection that disappears and more like a chronic inflammatory tendency that requires ongoing stabilization.

Toward a New Definition of Breathing Well

The authors ultimately argue for a more unified and patient-centered approach to asthma management. Future definitions of control, they suggest, should combine objective biological measures with the lived experience of patients themselves.

That means asking broader questions. Not simply: 

• Are you wheezing?

But also:

• Are you sleeping deeply?
• Can you exercise freely?
• Are you avoiding activities without realizing it?
• How often do you rely on your rescue inhaler?
• Do your lungs remain stable even when life becomes stressful, polluted, or physically demanding?

In many ways, the emerging vision of asthma care resembles a larger trend across modern medicine: shifting from crisis management to preservation of long-term function and resilience. The goal is no longer merely to survive asthma attacks. It is to maintain healthy, stable lungs quietly enough that patients can forget, at least temporarily, that asthma is there at all.​

Reference

1. Canonica GW, Spanevello A, de Llano LP, et al. Is asthma control more than just an absence of symptoms? An expert consensus statement. Respir Med. 2022;202:106942. doi:10.1016/j.rmed.2022.106942

2. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59-99. doi:10.1164/rccm.200801-060ST

3. Dubin S, Patak P, Jung D. Update on Asthma Management Guidelines. Mo Med. 2024;121(5):364-367.

4. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59-65. doi:10.1016/j.jaci.2003.09.008

5. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13. Published 2006 Jun 13. doi:10.1186/1471-2466-6-13